Vascular Pharmacology

Titel Veröffentlichungsdatum Sprache Zitate
Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation2015/10/01English45
Cellular and molecular mechanisms of vascular injury in diabetes — Part II: Cellular mechanisms and therapeutic targets2011/03/01English45
Emodin and rhein inhibit LIGHT-induced monocytes migration by blocking of ROS production2010/07/01English45
Sulforaphane suppresses vascular adhesion molecule-1 expression in TNF-α-stimulated mouse vascular smooth muscle cells: Involvement of the MAPK, NF-κB and AP-1 signaling pathways2012/03/01English44
Innate and adaptive immunity in atherosclerosis2018/08/01English44
Effects of Astragalus membranaceus and its main components on the acute phase endothelial dysfunction induced by homocysteine2007/04/01English44
NAD+-dependent SIRT1 deactivation has a key role on ischemia–reperfusion-induced apoptosis2015/07/01English44
Pitavastatin inhibits lysophosphatidic acid-induced proliferation and monocyte chemoattractant protein-1 expression in aortic smooth muscle cells by suppressing Rac-1-mediated reactive oxygen species generation2007/04/01English44
Aspirin and PPAR-α activators inhibit monocyte chemoattractant protein-1 expression induced by high glucose concentration in human endothelial cells2006/06/01English44
Protective effect of lupeol and its ester on cardiac abnormalities in experimental hypercholesterolemia2007/06/01English44
Nitric oxide and the biology of pregnancy2018/11/01English44
Long non-coding RNAs in vascular biology and disease2019/03/01English43
Discovering cardiac pericyte biology: From physiopathological mechanisms to potential therapeutic applications in ischemic heart disease2016/11/01English43
Atherosclerosis induced by a high-fat diet is alleviated by lithium chloride via reduction of VCAM expression in ApoE-deficient mice2010/11/01English43
Ginsenoside Rb1 attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of the JNK and p38 signaling pathways2015/10/01English43
Glycoprotein IIb/IIIa inhibitors: The resurgence of tirofiban2016/03/01English43
Attenuation of nitric oxide- and prostaglandin-independent vasodilation of retinal arterioles induced by acetylcholine in streptozotocin-treated rats2007/03/01English43
Arterial stiffness and sedentary lifestyle: Role of oxidative stress2016/04/01English42
Characterization of four different effects elicited by H2O2 in rat aorta2005/08/01English42
Statin therapy in lower limb peripheral arterial disease: Systematic review and meta-analysis2014/11/01English42
Heavy menstrual bleeding in women treated with rivaroxaban and vitamin K antagonists and the risk of recurrent venous thromboembolism2016/12/01English42
Inhibition of Jak2 phosphorylation attenuates pressure overload cardiac hypertrophy2006/12/01English42
A3 adenosine receptor-mediated protection of the ischemic heart2005/04/01English42
The BMP type II receptor is located in lipid rafts, including caveolae, of pulmonary endothelium in vivo and in vitro2006/01/01English42
IGF-1 signaling in neonatal hypoxia-induced pulmonary hypertension: Role of epigenetic regulation2015/10/01English42
Inhibitory effects of ethanol extract from Radix Ophiopogon japonicus on venous thrombosis linked with its endothelium-protective and anti-adhesive activities2005/09/01English42
Thyroid hormone and myocardial mitochondrial biogenesis2010/03/01English41
Trichostatin A prevents neointimal hyperplasia via activation of Krüppel like factor 42011/11/01English41
Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice2017/09/01English41
Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways2015/01/01English41